P

Inventor

BRADLEY ALLAN

GB47 patents
⚠️ This page may combine multiple inventors who share the name “BRADLEY ALLAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

KYMAB LTD

29 patents
US9505827B2Nov 29, 2016

Animal models and therapeutic molecules

KYMAB LTD27 citations98
US9434782B2Sep 6, 2016

Animal models and therapeutic molecules

KYMAB LTD31 citations98
US9938357B2Apr 10, 2018

Animal models and therapeutic molecules

KYMAB LTD21 citations94
US9938358B2Apr 10, 2018

Animal models and therapeutic molecules

KYMAB LTD19 citations94
US9924705B2Mar 27, 2018

Animal models and therapeutic molecules

KYMAB LTD20 citations94
US9896516B2Feb 20, 2018

Animal models and therapeutic molecules

KYMAB LTD20 citations94
US10165763B2Jan 1, 2019

Animal models and therapeutic molecules

KYMAB LTD13 citations93
US10149462B2Dec 11, 2018

Animal models and therapeutic molecules

KYMAB LTD15 citations93
US10064398B2Sep 4, 2018

Animal models and therapeutic molecules

KYMAB LTD14 citations93
US9788534B2Oct 17, 2017

Animal models and therapeutic molecules

KYMAB LTD18 citations92
US9783593B2Oct 10, 2017

Antibodies, variable domains and chains tailored for human use

KYMAB LTD19 citations91
US10966412B2Apr 6, 2021

Animal models and therapeutic molecules

KYMAB LTD11 citations86
US10774155B2Sep 15, 2020

Animal models and therapeutic molecules

KYMAB LTD9 citations84
US10226033B2Mar 12, 2019

Animal models and therapeutic molecules

KYMAB LTD13 citations84
US9963716B2May 8, 2018

Chimaeric surrogate light chains (SLC) comprising human VpreB

KYMAB LTD12 citations83
US10730930B2Aug 4, 2020

Antibodies, variable domains and chains tailored for human use

KYMAB LTD9 citations82
US11606941B2Mar 21, 2023

Animal models and therapeutic molecules

KYMAB LTD1 citations73
US11564380B2Jan 31, 2023

Animal models and therapeutic molecules

KYMAB LTD1 citations73
US11399522B2Aug 2, 2022

Animal models and therapeutic molecules

KYMAB LTD2 citations73
US10337000B2Jul 2, 2019

Expression vector production and high-throughput cell screening

KYMAB LTD4 citations72
US11066464B2Jul 20, 2021

Anti-malarial antibodies that bind circumsporozoite protein

KYMAB LTD4 citations65
US11371042B2Jun 28, 2022

Expression vector production and high-throughput cell screening

KYMAB LTD0 citations62
US11297810B2Apr 12, 2022

Animal models and therapeutic molecules

KYMAB LTD1 citations62
US11820810B2Nov 21, 2023

Antibodies, variable domains and chains tailored for human use

KYMAB LTD0 citations61
US11812731B2Nov 14, 2023

Animal models and therapeutic molecules

KYMAB LTD0 citations61
US12473378B2Nov 18, 2025

Antigen-binding molecules comprising unpaired variable domains

KYMAB LTD0 citations53
US11707056B2Jul 25, 2023

Animals, repertoires and methods

KYMAB LTD0 citations52
US11920128B2Mar 5, 2024

Methods, cells and organisms

KYMAB LTD0 citations50
US12384855B2Aug 12, 2025

PCSK9 antagonists

KYMAB LTD0 citations46

BAYLOR COLLEGE MEDICINE

8 patents

BRADLEY ALLAN

3 patents

LEXICON GENETICS INC

3 patents

Kymab Limited; The Bennet Building (B930)

1 patent

SEQWRIGHT INC

1 patent

SPECTRAL GENOMICS INC

1 patent

(unassigned)

1 patent